Skip to Main Content

Paper Details

Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother
3
2023
Author NameAffiliation
Evan Y YuFred Hutchinson Cancer Center, University of Washington
Bruce MontgomeryFred Hutchinson Cancer Center, University of Washington
Heather H ChengFred Hutchinson Cancer Center, University of Washington
  • 1 - 3

Datasets

Release 1.2